Cardiovascular disease recurrence and long-term mortality in a tri-ethnic British cohort.

cardiac risk factors and prevention epidemiology quality and outcomes of care

Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
26 May 2021
Historique:
received: 24 06 2020
revised: 16 09 2020
accepted: 21 09 2020
medline: 18 10 2020
pubmed: 18 10 2020
entrez: 17 10 2020
Statut: epublish

Résumé

Ethnic differences in cardiovascular disease incidence, but not cardiovascular disease recurrence, are reported. We characterised long-term risk of major adverse cardiovascular event (MACE) and mortality following a non-fatal cardiovascular event in a British cohort of South Asians, African Caribbeans and Europeans. We identified index and recurrent cardiovascular events and mortality between 1988 and 2017 using hospital records and death registry. Using multivariable hazards models, we separately calculated the adjusted HR of MACE and death following index event, adjusting for demographics, vascular and lifestyle risk factors. Using interaction terms, we evaluated if decade of index event modified the association between ethnicity and outcomes. South Asians were younger at the index event (median age 66 years, n=396) than Europeans (69 years, n=335) and African Caribbeans (70 years, n=70). During 4228 person-years, of the 801 patients, 537 developed MACE and 338 died, with the highest crude rate of MACE in South Asians. On adjustment of baseline factors, compared with the Europeans, the higher risk of MACE (HR 0.97, 95% CI 0.77 to 1.21) and the lower risk of mortality (HR 0.95, 95% CI 0.72 to 1.26) in South Asians was eliminated. African Caribbeans had similar outcomes to Europeans (HR MACE 1.04, 95% CI 0.74 to 1.47; and HR death 1.07, 95% CI 0.70 to 1.64). Long-term survival following an index event improved in South Asians (p Baseline vascular risk factors explained the observed ethnic variation in cardiovascular disease recurrence and long-term mortality, with a relative improvement in survival of minority ethnic groups over time.

Identifiants

pubmed: 33067326
pii: heartjnl-2020-317641
doi: 10.1136/heartjnl-2020-317641
pmc: PMC8165149
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

996-1002

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CS/13/1/30327
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00019/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00019/4
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: NC receives funds from AstraZeneca for work on a trial data safety and monitoring committee. MVV holds a Fellowship Award from the Canadian Institutes of Health Research and the Prince Mahidol Marmot Fellowship Award.

Auteurs

Manav V Vyas (MV)

Division of Neurology, University of Toronto, Toronto, Ontario, Canada.

Nish Chaturvedi (N)

MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, UK.

Alun D Hughes (AD)

MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, UK.

Michael Marmot (M)

Epidemiology and Public Health, University College London, London, UK.

Therese Tillin (T)

MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, UK t.tillin@ucl.ac.uk.

Classifications MeSH